In patients with difficulty gaining or keeping muscle mass, particularly those undergoing weight loss, Sermorelin is the more targeted intervention
GLP-1s are the most successful, clinically-backed tools for diabetes and weight management on the planet, but side effects like nausea, diarrhea, constipation, fatigue, muscle loss are getting in the way
These medications are safe and highly effective for patients who have experienced weight regain following bariatric surgery
Safety, tolerability, pharmacokinetics, and pharmacodynamics of the first-in-class GLP-1 and amylin receptor agonist, amycretin: a first-in-human, phase 1, double-blind, randomised, placebo-controlled trial